SEC Filings for Global Blood Therapeutics Inc. (GBT)

$ 54.10 r      -8.33 (-13.34%) Volume: 6.09m 4:00 PM EDT Jun 26, 2019
Filing Type:
Form TypeForm DescriptionPagesDateView
424B5Prospectus filed under Rule 424(b)(5)6706/25/2019
4Statement of changes in beneficial ownership of securities106/20/2019
4Statement of changes in beneficial ownership of securities106/20/2019
4Statement of changes in beneficial ownership of securities106/20/2019
4Statement of changes in beneficial ownership of securities106/20/2019
4Statement of changes in beneficial ownership of securities106/20/2019
4Statement of changes in beneficial ownership of securities106/20/2019
4Statement of changes in beneficial ownership of securities106/20/2019
4Statement of changes in beneficial ownership of securities106/20/2019
8-KReport of unscheduled material events or corporate changes.306/20/2019
8-KReport of unscheduled material events or corporate changes.406/14/2019
10-QQuarterly report with a continuing view of a company's financial position6605/10/2019
8-KReport of unscheduled material events or corporate changes.405/08/2019
DEFA14AAdditional proxy soliciting materials - definitive404/29/2019
DEFA14AAdditional proxy soliciting materials - definitive504/29/2019
<<
First
<
Prev
123456789101112131415